Length of hospital stay · adults receiving EN via nasogastric or gastrostomy tube
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether no monitoring changes mortality (at the end of compared with frequent monitoring (12 hours or less) of gastric residual volume (very low certainty).
1 finding from 1 review
Pneumonia · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether no monitoring changes pneumonia (until discontinued or up to 28 days) compared with frequent monitoring (12 hours or less) of gastric residual volume (very low certainty).
1 finding from 1 review
Length of hospital stay · adults receiving EN via nasogastric or gastrostomy tube
1 finding from 1 review
Mean upper extremity activity · treating upper extremity deficits in individuals with hemiparesis after stroke
1 finding from 1 review
Mean quality of life: not reported · treating upper extremity deficits in individuals with hemiparesis after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Costs ‐ not reported · treating upper extremity deficits in individuals with hemiparesis after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean adverse events: not reported · treating upper extremity deficits in individuals with hemiparesis after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean upper extremity impairment · treating upper extremity deficits in individuals with hemiparesis after stroke
1 finding from 1 review
Activities of daily living · treating upper extremity deficits in individuals with hemiparesis after stroke
1 finding from 1 review
Mean quality of Life · treating upper extremity deficits in individuals with hemiparesis after stroke
1 finding from 1 review
Costs ‐ not reported · treating upper extremity deficits in individuals with hemiparesis after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean adverse events: not reported · treating upper extremity deficits in individuals with hemiparesis after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean upper extremity activity · treating upper extremity deficits in individuals with hemiparesis after stroke
1 finding from 1 review
Mean upper extremity impairment · treating upper extremity deficits in individuals with hemiparesis after stroke
1 finding from 1 review
Activities of daily living · treating upper extremity deficits in individuals with hemiparesis after stroke
1 finding from 1 review
Abstinence · individuals dependent on illicit opiates
Dihydrocodeine showed no clear difference in abstinence Assessed by urinalysis post‐detoxification compared with buprenorphine (low certainty).
3 findings from 1 review
RR 0.42 [0.11, 1.57]
2 studies · 150 participants
Low
RR 0.59 [0.26, 1.31]
2 studies · 150 participants
Low
RR 0.59 [0.25, 1.39]
2 studies · 150 participants
Low
Serious adverse events or adverse events · individuals dependent on illicit opiates
1 finding from 1 review
Treatment retention Early dropout · individuals dependent on illicit opiates
Dihydrocodeine showed no clear difference in treatment retention Early dropout compared with buprenorphine (low certainty).
1 finding from 1 review
Abstinence · individuals dependent on illicit opiates
Dihydrocodeine showed no clear difference in abstinence compared with methadone (low certainty).
1 finding from 1 review